Picture of Verve Therapeutics logo

VERV — Verve Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Verve Therapeutics Q1 Collaboration Revenue USD 32.976 Million

May 14 (Reuters) - Verve Therapeutics Q1 net income USD -31.033 million.

Recent news on Verve Therapeutics

See all news